Breast Cancer

Latest News


The Food and Drug Administration has granted an accelerated approval to the frontline combination of Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for patients with unresectable locally advanced or metastatic PD-L1–positive triple-negative breast cancer (TNBC).

What started as a hangnail turned into one of the most difficult late effects of breast cancer. This survivor found swimming to be a viable treatment for her lymphedema.

Survivors with children face some of the biggest challenges when it comes to visualizing the future. After my breast cancer diagnosis in 1986, it was my daughter's future, rather than my own, for which I bargained.